TIAA Wealth Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$860K Buy
14,907
+617
+4% +$35.4K 0.01% 195
2026
Q1
$866K Buy
+14,290
New +$833K 0.01% 176

Other funds holding BMY

TIAA Wealth Investment Management's BMY Position: Q2 2026 in Review

TIAA Wealth Investment Management increased its Bristol-Myers Squibb (BMY) stake by 4.3% in Q2 2026, buying an estimated $35.4K and bringing the position to 14,907 shares worth $860K. The position accounts for 0.01% of the portfolio, ranked #195.

TIAA Wealth Investment Management first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $866K in Q1 2026. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • TIAA Wealth Investment Management held 14,907 shares of Bristol-Myers Squibb worth $860K as of Q2 2026.
  • TIAA Wealth Investment Management bought 617 Bristol-Myers Squibb shares in Q2 2026, an estimated $35.4K.
  • Bristol-Myers Squibb made up 0.01% of TIAA Wealth Investment Management's portfolio in Q2 2026, its #195 holding.
  • TIAA Wealth Investment Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
  • TIAA Wealth Investment Management's Bristol-Myers Squibb position peaked at $866K in Q1 2026.
  • 2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on TIAA Wealth Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.